Publications (99) Carlos Eduardo De Andrea publications

filter_list

2025

  1. 4-1BB agonist targeted to fibroblast activation protein α synergizes with radiotherapy to treat murine breast tumor models

    Journal for immunotherapy of cancer, Vol. 13, Núm. 2

  2. Cross-priming in cancer immunology and immunotherapy

    Nature Reviews Cancer, Vol. 25, Núm. 4, pp. 249-273

  3. New evidence for fibrocartilaginous dysplasia representing a variant of fibrous dysplasia

    Journal of Clinical Pathology

  4. The C5a/C5aR1 Axis Promotes Migration of Tolerogenic Dendritic Cells to Lymph Nodes, Impairing the Anticancer Immune Response

    Cancer immunology research, Vol. 13, Núm. 3, pp. 384-399

2024

  1. Alpelisib decreases nevocytes of congenital melanocytic nevi

    Journal of the European Academy of Dermatology and Venereology, Vol. 38, Núm. 6, pp. 1147-1151

  2. Analysis of Tumor Microenvironment Changes after Neoadjuvant Chemotherapy with or without Bevacizumab in Advanced Ovarian Cancer (GEICO-89T/ MINOVA Study)

    Clinical Cancer Research, Vol. 30, Núm. 1, pp. 176-186

  3. Dietary-Based Diabetes Risk Score and breast cancer: a prospective evaluation in the SUN project

    Journal of Physiology and Biochemistry

  4. Immunotherapy and lung cytopathology: Overview and possibilities

    Cytopathology, Vol. 35, Núm. 2, pp. 213-217

  5. Low-Dose Ionizing γ-Radiation Elicits the Extrusion of Neutrophil Extracellular Traps

    Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 30, Núm. 18, pp. 4131-4142

  6. MHC class I and II-deficient humanized mice are suitable tools to test the long-term antitumor efficacy of immune checkpoint inhibitors and T-cell engagers

    Journal for immunotherapy of cancer, Vol. 12, Núm. 9

  7. Multiplex spatial analysis reveals increased CD137 expression and m-MDSC neighboring tumor cells in refractory classical Hodgkin Lymphoma

    OncoImmunology, Vol. 13, Núm. 1

  8. NKG2C/KLRC2 tumor cell expression enhances immunotherapeutic efficacy against glioblastoma

    Journal for immunotherapy of cancer, Vol. 12, Núm. 8

  9. Predictive and Dynamic Signature for Antiangiogenics in Combination with a PD1 Inhibitor in Soft-Tissue Sarcoma: Correlative Studies Linked to the IMMUNOSARC Trial

    Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 30, Núm. 22, pp. 5192-5206

  10. Short-term cultured tumor fragments to study immunotherapy combinations based on CD137 (4-1BB) agonism

    OncoImmunology, Vol. 13, Núm. 1

  11. Spatially resolved tissue imaging to analyze the tumor immune microenvironment: beyond cell-type densities

    Journal for immunotherapy of cancer, Vol. 12, Núm. 5

2023

  1. CD137 (4-1BB) requires physically associated cIAPs for signal transduction and antitumor effects

    Science advances, Vol. 9, Núm. 33, pp. eadf6692

  2. Cell-Specific Dysregulation of Iron and Oxygen Homeostasis as a Novel Pathophysiology in PSP

    Annals of Neurology, Vol. 93, Núm. 3, pp. 431-445

  3. Characterization of the immune infiltrate in mouse tissue by multiplex immunofluorescence

    Methods in Cell Biology, Vol. 174, pp. 43-53

  4. In situ detection of vaccine mRNA in the cytoplasm of hepatocytes during COVID-19 vaccine-related hepatitis

    Journal of Hepatology

  5. In situ tumour arrays reveal early environmental control of cancer immunity

    Nature, Vol. 618, Núm. 7966, pp. 827-833